318 related articles for article (PubMed ID: 27266722)
21. Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer.
Dong F; Zhou L; Wang S; Mao J; Liu C; Shi W
Front Endocrinol (Lausanne); 2021; 12():790730. PubMed ID: 35211090
[TBL] [Abstract][Full Text] [Related]
22. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
23. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
[TBL] [Abstract][Full Text] [Related]
24. Should small papillary thyroid cancer be observed? A population-based study.
Nilubol N; Kebebew E
Cancer; 2015 Apr; 121(7):1017-24. PubMed ID: 25425528
[TBL] [Abstract][Full Text] [Related]
25. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
26. Treatment patterns of aging Americans with differentiated thyroid cancer.
Park HS; Roman SA; Sosa JA
Cancer; 2010 Jan; 116(1):20-30. PubMed ID: 19908255
[TBL] [Abstract][Full Text] [Related]
27. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.
Adam MA; Pura J; Goffredo P; Dinan MA; Hyslop T; Reed SD; Scheri RP; Roman SA; Sosa JA
J Clin Endocrinol Metab; 2015 Jan; 100(1):115-21. PubMed ID: 25337927
[TBL] [Abstract][Full Text] [Related]
28. Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades.
Goffredo P; Sosa JA; Roman SA
World J Surg; 2013 Jul; 37(7):1599-605. PubMed ID: 23525600
[TBL] [Abstract][Full Text] [Related]
29. Hurthle cell carcinoma: a population-level analysis of 3311 patients.
Goffredo P; Roman SA; Sosa JA
Cancer; 2013 Feb; 119(3):504-11. PubMed ID: 22893587
[TBL] [Abstract][Full Text] [Related]
30. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
[No Abstract] [Full Text] [Related]
31. Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
Jain NK; Mostoufi-Moab S; Hawkes CP; Nelson ND; Surrey LF; Jones ZS; Adzick NS; Kazahaya K; Bauer AJ
Thyroid; 2020 Jul; 30(7):1037-1043. PubMed ID: 31573414
[No Abstract] [Full Text] [Related]
32. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the predicted impact of changes to the AJCC/TMN staging system for differentiated thyroid cancer (DTC): A prospective observational study of patients in South East Scotland.
Hulse K; Williamson A; Gibb FW; Conn B; Nixon IJ
Clin Otolaryngol; 2019 May; 44(3):330-335. PubMed ID: 30720920
[TBL] [Abstract][Full Text] [Related]
34. Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer.
Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA
Ann Surg Oncol; 2016 Feb; 23(2):403-9. PubMed ID: 26416710
[TBL] [Abstract][Full Text] [Related]
35. Lymph node metastases in differentiated thyroid cancer under 2 cm.
Reddy RM; Grigsby PW; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1050-4; discussion 1054-5. PubMed ID: 17188156
[TBL] [Abstract][Full Text] [Related]
36. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
[TBL] [Abstract][Full Text] [Related]
37. Important Therapeutic Considerations in T1b Penile Cancer: Prognostic Significance and Adherence to Treatment Guidelines.
Zhu Y; Gu WJ; Xiao WJ; Wang BH; Azizi M; Spiess PE; Ye DW
Ann Surg Oncol; 2019 Feb; 26(2):685-691. PubMed ID: 30565040
[TBL] [Abstract][Full Text] [Related]
38. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
Adam MA; Pura J; Goffredo P; Dinan MA; Reed SD; Scheri RP; Hyslop T; Roman SA; Sosa JA
J Clin Oncol; 2015 Jul; 33(21):2370-5. PubMed ID: 26077238
[TBL] [Abstract][Full Text] [Related]
39. Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population.
Sharma RK; Huang B; Lee JA; Kuo JH
J Surg Res; 2021 Jul; 263():207-214. PubMed ID: 33690052
[TBL] [Abstract][Full Text] [Related]
40. Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.
Orosco RK; Hussain T; Brumund KT; Oh DK; Chang DC; Bouvet M
Thyroid; 2015 Jan; 25(1):125-32. PubMed ID: 25369076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
